Corrigendum to: Chitosan prevents gentamicin-induced nephrotoxicity via a carbonyl stress-dependent pathway (BioMed Research International (2015) 2015 (675714) DOI: 10.1155/2015/675714);Chitosan prevents gentamicin-induced nephrotoxicity via a carbonyl stress-dependent pathway

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chou, Chu Kung ^a,b   Li, Yi Chieh ^c   Chen, Shih Ming ^c   Shih, Yi Min ^c   Lee, Jen Ai ^c  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CREATININE; GENTAMICIN; METFORMIN; METHYLGLYOXAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; PARTICLE SIZE; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; HEMODIALYSIS; HUMAN; KIDNEY; KIDNEY DISEASES; METABOLISM; OXIDATIVE STRESS;

RATTUS;

ANIMALS; BLOOD UREA NITROGEN; CHITOSAN; GENTAMICINS; HUMANS; KIDNEY; KIDNEY DISEASES; METABOLIC NETWORKS AND PATHWAYS; METFORMIN; OXIDATIVE STRESS; PYRUVALDEHYDE; RATS; RENAL DIALYSIS;

EID: 84928779844     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/7686249     Document Type: Erratum

References (40)

1. H. D. Humes, "Aminoglycoside nephrotoxicity, " Kidney International, vol. 33, no. 4, pp. 900-911, 1988.
2. J. M. Lopez-Novoa, Y. Quiros, L. Vicente, A. I. Morales, and F. J. Lopez-Hernandez, "New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view, " Kidney International, vol. 79, no. 1, pp. 33-45, 2011.
3. G. Laurent, B. K. Kishore, and P. M. Tulkens, "Aminoglycosideinduced renal phospholipidosis and nephrotoxicity, " Biochemical Pharmacology, vol. 40, no. 11, pp. 2383-2392, 1990.
4. B. P. Manali, S. Deshpande, and G. Shah, "Evaluation of efficacy of vitamin e and N-Acetyl cysteine in gentamicin-induced nephrotoxicity in rats, " Renal Failure, vol. 33, no. 3, pp. 341-347, 2011.
5. H. N. Varzi, S. Esmailzadeh, H. Morovvati, R. Avizeh, A. Shahriari, and M. E. Givi, "Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs, " Journal of Veterinary Pharmacology and Therapeutics, vol. 30, no. 5, pp. 477-481, 2007.
6. A. B. Abdel-N Aim, M. H. Abdel-Wahab, and F. F. Attia, "Protective effects of vitamin E and probucol against gentamicininduced nephrotoxicity in rats, " Pharmacological Research, vol. 40, no. 2, pp. 183-187, 1999.
7. A. I. Morales, D. Detaille, M. Prieto et al., "Metformin prevents experimental gentamicin-induced nephropathyby a mitochondria-dependent pathway, " Kidney International, vol. 77, no. 10, pp. 861-869, 2010.
8. Y.-C. Li, Y.-M. Shih, and J.-A. Lee, "Gentamicin caused renal injury deeply related to methylglyoxal and-(carboxyethyl) lysine (CEL), " Toxicology Letters, vol. 219, no. 1, pp. 85-92, 2013.
9. M. Krautwald and G. Münch, "Advanced glycation end products as biomarkers and gerontotoxins-a basis to explore methylglyoxal-lowering agents for Alzheimer's disease" Experimental Gerontology, vol. 45, no. 10, pp. 744-751, 2010.
10. R. Nagai, T. Araki, C. M. Hayashi, F. Hayase, and S. Horiuchi, "Identification of N-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 788, no. 1, pp. 75-84, 2003.
11. J. A. Mosquera, "Role of the receptor for advanced glycation end products (RAGE) in inflammation, " Investigacion Clinica, vol. 51, no. 2, pp. 257-268, 2010.
12. J. Xue, R. Ray, D. Singer et al., "The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs, " Biochemistry, vol. 53, no. 20, pp. 3327-3335, 2014.
13. N. Rabbani and P. J. Thornalley, "Glyoxalase in diabetes, obesity and related disorders, " Seminars in Cell and Developmental Biology, vol. 22, no. 3, pp. 309-317, 2011.
14. U. Ahmed, P. J. Thornalley, and N. Rabbani, "Possible role of methylglyoxal and glyoxalase in arthritis, " Biochemical Society Transactions, vol. 42, no. 2, pp. 538-542, 2014.
15. C. Tikellis, R. J. Pickering, D. Tsorotes et al., "Dicarbonyl stress in the absence of hyperglycemia increases endothelial inflammation and atherogenesis similar to that observed in diabetes, " Diabetes, vol. 63, no. 11, pp. 3915-3925, 2014.
16. M. U. Ahmed, E. Brinkmann Frye, T. P. Degenhardt, S. R. Thorpe, and J. W. Baynes, "N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins, " The Biochemical Journal, vol. 324, part 2, 1997.
17. L.-C. Chen, W.-D. Chiang, W.-C. Chen et al., "Influence of alanine uptake on Staphylococcus aureus surface charge and its susceptibility to two cationic antibacterial agents, nisin and low molecular weight chitosan, " Food Chemistry, vol. 135, no. 4, pp. 2397-2403, 2012.
18. S. Gao, J. Chen, X. Xu et al., "Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting, " International Journal of Pharmaceutics, vol. 255, no. 1-2, pp. 57-68, 2003.
19. F. Seyfarth, S. Schliemann, P. Elsner, and U.-C. Hipler, "Antifungal effect of high-and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-d-glucosamine against Candida albicans, Candida krusei and Candida glabrata, " International Journal of Pharmaceutics, vol. 353, no. 1-2, pp. 139-148, 2008.
20. A. Vila, A. Sánchez, K. Janes et al., "Low molecular weight chitosan nanoparticles as newcarriers for nasal vaccine delivery in mice, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 57, no. 1, pp. 123-131, 2004.
21. K. Hayashi and M. Ito, "Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice, " Biological & Pharmaceutical Bulletin, vol. 25, no. 2, pp. 188-192, 2002.
22. S.-B. Jing, L. Li, D. Ji, Y. Takiguchi, and T. Yamaguchi, "Effect of chitosan on renal function in patients with chronic renal failure, " The Journal of Pharmacy and Pharmacology, vol. 49, no. 7, pp. 721-723, 1997.
23. R. Xing, S. Liu, H. Yu et al., "Protective effect of sulfated chitosan of C3 sulfation on glycerol-induced acute renal failure in rat kidney, " International Journal of Biological Macromolecules, vol. 65, pp. 383-388, 2014.
24. C. Lamanna, M. Monami, N. Marchionni, and E. Mannucci, "Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials, " Diabetes, Obesity &Metabolism, vol. 13, no. 3, pp. 221-228, 2011.
25. J.-A. Lee, Y.-C. Tsai, H.-Y. Chen et al., "Fluorimetric determination of D-lactate in urine of normal and diabetic rats by columnswitching high-performance liquid chromatography, " Analytica Chimica Acta, vol. 534, no. 2, pp. 185-191, 2005.
26. H. Kaltwasser and H. G. Schlegel, "NADH-dependent coupled enzyme assay for urease and other ammonia-producing systems, " Analytical Biochemistry, vol. 16, no. 1, pp. 132-138, 1966.
27. D. C. Houghton, M. Hartnett, M. Campbell-Boswell, G. Porter, and W. Bennett, "A light and electron microscopic analysis of gentamicin nephrotoxicity in rats, " American Journal of Pathology, vol. 82, no. 3, pp. 589-612, 1976.
28. Y.-C. Li, S.-H. Tsai, S.-M. Chen et al., "Aristolochic acid-induced accumulation of methylglyoxal and N-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy, " Biochemical and Biophysical Research Communications, vol. 423, no. 4, pp. 832-837, 2012.
29. N. Rabbani, S. S. Alam, S. Riaz et al., "High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study, " Diabetologia, vol. 52, no. 2, pp. 208-212, 2009.
30. P. J. Thornalley, "Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts, " Archives of Biochemistry and Biophysics, vol. 419, no. 1, pp. 31-40, 2003.
31. G. P. Ferguson, S. VanPatten, R. Bucala, and Y. Al-Abed, "Detoxification of methylglyoxal by the nucleophilic bidentate, phenylacylthiazolium bromide, " Chemical Research in Toxicology, vol. 12, no. 7, pp. 617-622, 1999.
32. R. H. Nagaraj, P. Sarkar, A. Mally, K. M. Biemel, M. O. Lederer, and P. S. Padayatti, "Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal, " Archives of Biochemistry and Biophysics, vol. 402, no. 1, pp. 110-119, 2002.
33. C. R. Choi, E. K. Kim, Y. S. Kim et al., "Chitooligosaccharides decreases plasma lipid levels in healthy men, " International Journal of Food Sciences and Nutrition, vol. 63, no. 1, pp. 103-106, 2012.
34. F. Karadeniz and S. K. Kim, "Antidiabetic activities of chitosan and its derivatives: a mini review, " Advances in Food and Nutrition Research, vol. 73, pp. 33-44, 2014.
35. P. J. Beisswenger, S. K. Howell, G. B. Russell, M. E. Miller, S. S. Rich, and M. Mauer, "Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products, " Diabetes Care, vol. 36, no. 10, pp. 3234-3239, 2013.
36. M. L. M. Lieuw-A-Fa, V. W. M. van Hinsbergh, T. Teerlink et al., "Increased levels of-(carboxymethyl)lysine and-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlationwithmarkers of endothelial dysfunction, " NephrologyDialysis Transplantation, vol. 19, no. 3, pp. 631-636, 2004.
37. C. VanNguyen, "Toxicity of the AGEs generated fromtheMaillard reaction: on the relationship of food-AGEs and biological-AGEs, " Molecular Nutrition and Food Research, vol. 50, no. 12, pp. 1140-1149, 2006.
38. C. Srey, G. L. J. Hull, L. Connolly, C. T. Elliott, M. D. Del Castillo, and J. M. Ames, "Effect of inhibitor compounds on N-(carboxymethyl)lysine (CML) and N-(carboxyethyl)lysine (CEL) formation in model foods, " Journal of Agricultural and Food Chemistry, vol. 58, no. 22, pp. 12036-12041, 2010.
39. H. Qiao, M. Sun, Z. Su et al., "Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan, " Biomaterials, vol. 35, no. 25, pp. 7157-7171, 2014.
40. X.-K. Chen, Y.-H. Wei, J.-N. Yao, Y.-M. Zhao, X.-G. Shang, and F.-Z. Li, "Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property, " Zhongguo Zhong Yao Za Zhi, vol. 38, no. 4, pp. 548-552, 2013.